Health
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas – ABC News
AstraZeneca and Oxford University’s potential COVID-19 vaccine produces a strong immune response in those aged over 70.
Oxford University and AstraZeneca’s potential COVID-19 vaccine produced a strong immune response in older adults, newly published data has showed, with researchers expecting to release late-stage trial results by Christmas.
Key points:
- Late stage Oxford-AstraZeneca trials have shown it develops antibody and T-cell responses in elderly patients
- Rival drugmakers Pfizer-BioNTech and Moderna have recently pushed ahead in the race for a COVID vaccine
- Researchers report no serious side effects from the…
Continue Reading
-
General18 hours agoWondering about winter | The Spectator Australia
-
Noosa News17 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General17 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Business22 hours agoAre Domain Holdings shares undervalued?